Jounce Therapeutics, Inc. JNCE
1.88 +1.88
Day range unavailable
52-week range unavailable
News
businesswire.com Marketing Architects Partners with Jounce Media for Greater Transparency in CTV Buying MINNEAPOLIS--(BUSINESS WIRE)--Marketing Architects and Jounce Media partner to drive greater transparency and improved outcomes for CTV advertisers.
businesswire.com Jounce Media Designates Yahoo Backstage as the Open Web's Largest MFA-Free Supply Source NEW YORK--(BUSINESS WIRE)--Jounce Media has recognized Yahoo Backstage via the Yahoo DSP as the "largest MFA-free supply source on the open Web.".
zacks.com Jounce (JNCE) Up 21% on Accepting Concentra's Buyout Offer Jounce Therapeutics (JNCE) is set to be acquired by Concentra Biosciences, spurning an all-share merger deal with British biotech firm Redx Pharma.
pennystocks.com Penny Stocks To Buy Now: 7 To Watch Before Next Week Are these penny stocks to buy now or avoid entirely? The post Penny Stocks To Buy Now: 7 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
zacks.com Jounce (JNCE) Up 41% on Buyout Offer From Concentra Biosciences Jounce Therapeutics (JNCE) receives a proposal from Concentra Biosciences to acquire 100% equity stake in the company.
pennystocks.com 5 Top Penny Stocks To Buy In March According To Insiders Insiders are buying these penny stocks but are they worth the risk? The post 5 Top Penny Stocks To Buy In March According To Insiders appeared first on Penny Stocks to Buy, Picks, News and…
pennystocks.com Navigating Volatile Penny Stocks: Essential Tips for Investors Use these tips for investing in volatile penny stocks The post Navigating Volatile Penny Stocks: Essential Tips for Investors appeared first on Penny Stocks to Buy, Picks, News and Information |…
247wallst.com Tang Capital Partners Now Owns 10.2% of Jounce Therapeutics Fintel reports that Tang Capital Partners has filed a 13D form with the SEC disclosing ownership of 5.30MM shares of Jounce Therapeutics Inc (JNCE).
benzinga.com S&P 500 Down Over 1%; ThermoGenesis Shares Spike Higher U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 400 points on Wednesday. The Dow traded down 1.32% to 31,732.39 while the NASDAQ fell 0.24% to 11,400.70. The S&P…
benzinga.com Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
investorplace.com Why Is Jounce Therapeutics (JNCE) Stock Up 37% Today? Jounce Therapeutics (NASDAQ: JNCE ) stock is climbing higher on Wednesday after getting an unexpected acquisition bid from Concentra Biosciences. That acquisition offer has Concentra Biosciences…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023 
pennystocks.com Maximizing Returns With Penny Stocks: Day Trading Use these tips to make money with penny stocks when day trading The post Maximizing Returns With Penny Stocks: Day Trading appeared first on Penny Stocks to Buy, Picks, News and Information |…- benzinga.com Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023 
investorplace.com Why Is Jounce Therapeutics (JNCE) Stock Up 14% Today? Jounce Therapeutics (NASDAQ: JNCE ) stock is on the rise Thursday after the company revealed merger plans with Redx Pharma . Jounce Therapeutics and Redx Pharma will undergo a merger with an…
seekingalpha.com Jounce: Gilead's GS-1811 Buyout Allows A Further Bounce Jounce has recently announced that it has sold its entire rights to immunotherapy candidate GS-1181 to Gilead for $67 million. I expect the biotech company to now have around $170 million cash, with…
pennystocks.com How to Read Penny Stocks News and Use it to Profit Use these tips to read penny stocks market news The post How to Read Penny Stocks News and Use it to Profit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
benzinga.com Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal…
investorplace.com Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today? Jounce Therapeutics (NASDAQ: JNCE ) stock jumped after it sold rights to a cancer drug to Gilead Sciences (NASDAQ: GILD ). Shares were trading as high as $1.30 in the pre-market, after closing under…
reuters.com Gilead buys out rights to cancer therapy from Jounce for $67 mln Gilead Sciences will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics for $67 million, the drugmaker said on Tuesday.
marketwatch.com Jounce stock bounces more than 70% after Gilead acquires immunotherapy drug Jounce Therapeutics Inc. JNCE, -6.66% shares jumped more than 70% in after-hours trading Tuesday, following an announcement that Gilead Sciences Inc. GILD, +0.31% would completely acquire rights to…
businesswire.com Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics FOSTER CITY, Calif. & CAMBRIDGE, Mass.--( BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq: GILD) and Jounce Therapeutics, Inc. (Nasdaq: JNCE) amended their existing license agreement for GS-1811…
benzinga.com Stocks That Hit 52-Week Lows On Monday Monday saw 196 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 160 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday OnThursday, 137 stocks made new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022 Upgrades
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 63 stocks hit new 52-week lows.- benzinga.com Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday Gainers
- benzinga.com Earnings Scheduled For November 10, 2022 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 413 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 446 companies hit new 52-week lows.
globenewswire.com Jounce Therapeutics to Present Multiple Posters at the Society for Immunotherapy of Cancer's (SITC) 37th Annual Meeting and the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) Annual Congress - Two preclinical posters highlighting the JTX-1484 program and LILRB family at SITC 2022 -- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 528 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 930 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 361 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 456 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.
globenewswire.com Jounce Therapeutics to Participate in the Upcoming Investor Conferences CAMBRIDGE, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and…
zacks.com Jounce (JNCE) SELECT Study Fails to Meet Goal, Stock Down Jounce Therapeutics (JNCE) declines as its mid-stage study, SELECT, evaluating vopratelimab in lung cancer patients, fails to meet the primary endpoint.- benzinga.com Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session Gainers NewAge, Inc. (NASDAQ: NBEV) rose 54.4% to $0.3220.
- benzinga.com Earnings Scheduled For August 4, 2022 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 269 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During the Thursday's session, 100 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 94 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 215 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.